Oncolytic Adenovirus TILT-123 and Avelumab for Treatment of Solid Tumors Refractory to or Progressing After Anti-PD(L)1

Name: Oncolytic Adenovirus TILT-123 and Avelumab for Treatment of Solid Tumors Refractory to or Progressing After Anti-PD(L)1
License: Public Domain

TILT Biotherapeutics Ltd.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

melanoma

melanoma, head and neck squamous cell carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 303732
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.